[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346794-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346794-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mechanistic-insights-into-the-roles-of-astragalosides-and-astragalus-polysaccharides-in-gynecological-and-breast-cancers","Mechanistic insights into the roles of astragalosides and Astragalus polysaccharides in gynecological and breast cancers","","A review evaluates mechanistic roles of astragalosides and Astragalus polysaccharides (APS) derived from Astragalus membranaceus, a Qi-tonifying herb used as an adjuvant for female-predominant malignancies including breast, ovarian and cervical cancers. It addresses unresolved crosstalk among PI3K/Akt/mTOR, Wnt/β-catenin, JNK/MAPK and TGF-β/Smad pathways and context-dependent control of programmed cell death, EMT and immune reprogramming. Evidence indicates inhibition of proliferation, enhanced cell death, reduced invasion and metastasis, reshaped antitumor immunity, improved macrophage polarization, and potentiation of chemotherapy with reduced toxicity, supporting integrative clinical use.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mechanistic-insights-into-the-roles-of-astragalosides-and-astragalus-polysaccharides-in-gynecological-and-breast-cancers/346794/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mechanistic-insights-into-the-roles-of-astragalosides-and-astragalus-polysaccharides-in-gynecological-and-breast-cancers/346794.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which cancers are covered in the review's scope?","Question",{"text":63,"@type":64},"The review focuses on breast, ovarian and cervical cancers, highlighting female-predominant malignancies treated with APS and AST as complementary agents.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What major signaling pathways are discussed as mechanistic gaps?",{"text":68,"@type":64},"Key uncertainties involve crosstalk among PI3K/Akt/mTOR, Wnt/β-catenin, JNK/MAPK and TGF-β/Smad pathways.",{"name":70,"@type":61,"acceptedAnswer":71},"How do APS and astragalosides affect tumor biology according to available data?",{"text":72,"@type":64},"They suppress tumor initiation and progression by inhibiting proliferation, inducing programmed cell death, attenuating invasion and metastasis, reshaping antitumor immunity and macrophage polarization, and improving chemotherapeutic efficacy while mitigating toxicity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346794,1790125842,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","ONCOLOGY REPORTS 55: 97, 2026  \nMechanistic insights into the roles of astragalosides and Astragalus polysaccharides in gynecological and breast cancers (Review)  \nRUIXIN LIU 1 , ZHANYU LIN2 , YUELIN LI 1 , YUETONG CI 1 , ZHENGQI GUO 1 and ZHENGUO XU3  \n1  \nDepartment of Acupuncture and Massage College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250000, P.R. China; 2Department of Traditional Chinese College, Shandong University of Traditional Chinese Medicine,  \n3  \nJinan, Shandong 250000, P.R. China; Department of General Surgery, Affiliated Hospital of Shandong  \nUniversity of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China  \nReceived November 11, 2025; Accepted February 11, 2026  \nDOI: 10. 3892/or.2026.9102  \nAbstract. Astragalus membranaceus , a Qi‑tonifying herb widely used in traditional Chinese medicine, has emerged as a promising adjuvant for female‑predominant malignan‑ cies, including breast, ovarian and cervical cancers. Its major bioactive constituents, Astragalus polysaccharides (APS) and astragalosides (AST), exert multitarget antitumor activi‑ ties and are widely used as complementary agents in clinical oncology. Nevertheless, key mechanistic gaps persist, particu‑ larly regarding the crosstalk among the PI3K/Akt/mTOR, Wnt/β‑catenin, JNK/MAPK and TGF‑β/Smad pathways, as well as the subtype‑ and context‑dependent regulation of molecular effectors governing programmed cell death, epithelial‑mesenchymal transition and immune reprogram‑ ming. This uncertainty constrains biomarker discovery and the rational design of combination regimens, thereby limiting the predictability of clinical benefit. The present review systematically collates current research on the molecular mechanisms and signaling networks through which APS and AST modulate breast, ovarian and cervical cancer biology. Available data indicate that these compounds suppress tumor initiation and progression by inhibiting proliferation, inducing programmed cell death, attenuating invasion and metastasis, reshaping antitumor immunity and macrophage polarization, and potentiating chemotherapeutic efficacy while mitigating treatment‑related toxicity. Overall, these insights aim to provide a mechanistic rationale for the clinical integration of A. membranaceus as an adjuvant therapy in gynecological and breast cancers, to bridge traditional Chinese medicine with contemporary pharmacology, and to support the development  \nCorrespondence to: Dr Zhenguo Xu, Department of General Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 16369 Jingshi Road, Jinan, Shandong 250355, P.R. China  \nE‑mail: [464584206@qq.com](464584206@qq.com)  \nKey words: Astragalus membranaceus, astragalosides, Astragalus polysaccharides, gynecological tumors, breast cancer  \nof individualized, integrative therapeutic strategies for breast, ovarian and cervical cancers.  \nContents  \n1. Introduction  \n2. Clinical applications and pharmacological basis of Astragalus membranaceus  \n3. Mechanisms of Astragalus active constituents in female malignancies  \n4. Discussion  \n1. Introduction  \nGynecological malignancies, particularly cervical and ovarian cancers, remain a major threat to women's health and contribute substantially to the global disease burden. Cervical cancer is the fourth most common cancer in women worldwide and accounts for ~6 . 5% of all female cancer cases (1) . It is often highly invasive and frequently diagnosed at an advanced stage, resulting in considerable mortality and morbidity (2) . Ovarian cancer carries an estimated lifetime risk of ~2% in women, and both incidence and mortality increase with age (3) . Each year,~239,000 new ovarian cancer cases are reported globally, with an estimated 152,000 associated deaths (4) . Because ovarian cancer is typically insidious in onset and effective screening strategies remain limited, the 5‑year survival rate remains \u003C20%, underscoring the urgency for improved ","cbCaiuyKmHhSMhGw","https://ap.wps.com/l/cbCaiuyKmHhSMhGw","pdf",2564273,12,"English","# Introduction\n## Clinical applications and pharmacological basis of Astragalus membranaceus\n## Mechanisms of Astragalus active constituents in female malignancies\n## Discussion","[{\"question\":\"Which cancers are covered in the review's scope?\",\"answer\":\"The review focuses on breast, ovarian and cervical cancers, highlighting female-predominant malignancies treated with APS and AST as complementary agents.\"},{\"question\":\"What major signaling pathways are discussed as mechanistic gaps?\",\"answer\":\"Key uncertainties involve crosstalk among PI3K/Akt/mTOR, Wnt/β-catenin, JNK/MAPK and TGF-β/Smad pathways.\"},{\"question\":\"How do APS and astragalosides affect tumor biology according to available data?\",\"answer\":\"They suppress tumor initiation and progression by inhibiting proliferation, inducing programmed cell death, attenuating invasion and metastasis, reshaping antitumor immunity and macrophage polarization, and improving chemotherapeutic efficacy while mitigating toxicity.\"}]","Mechanistic insights into the roles of astragalosides and Astragalus polysaccharides in gynecological and breast cancers | PDF",1790062769,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be21d5b73739ca9d674424d9c9db656c.webp",983,1357,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d8fe879a82449112d9c460872cb1515.webp",982,1356,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/636de739d64328af3afd28dab2c69b6e.webp",981,1354,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f73f1c4163b1a9fecdb8abe1bb6d584b.webp",980,1353]